Jiagui Song

Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer.

Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer.

Journal: EBioMedicine
Published: April 29, 2026

Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response.

Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response.

Journal: International journal of biological sciences
Published: January 05, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening.

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening.

Journal: Journal of visualized experiments : JoVE
Published: September 22, 2025

Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt signaling.

Piezo1 mediated scaffold-free rapid generation of self-mineralized bone organoids via activating Wnt signaling.

Journal: Materials today. Bio
Published: September 16, 2025

Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development, and precision medicine.

Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development, and precision medicine.

Journal: Protein & cell
Published: May 10, 2025

Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy.

Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy.

Journal: Frontiers in immunology
Published: April 01, 2025

Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatment.

Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatment.

Journal: EBioMedicine
Published: March 10, 2025

Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression.

Oleic acid activates TGFβ-Smad3 signaling to promote ovarian cancer progression.

Journal: Journal of ovarian research
Published: January 26, 2025

Systematic Identification of Molecular Signatures Dictating Therapeutic Effects of Clinically First-Line Chemotherapy Regimens for Human Gastric Cancer Patients Based on Organoid Model.

Systematic Identification of Molecular Signatures Dictating Therapeutic Effects of Clinically First-Line Chemotherapy Regimens for Human Gastric Cancer Patients Based on Organoid Model.

Journal: MedComm
Published: December 19, 2024

Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway.

Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway.

Journal: Science advances
Published: July 03, 2024

Kindlin-2 in myoepithelium controls luminal progenitor commitment to alveoli in mouse mammary gland.

Kindlin-2 in myoepithelium controls luminal progenitor commitment to alveoli in mouse mammary gland.

Journal: Cell death & disease
Published: July 01, 2023

FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.

FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.

Journal: Cell reports
Published: January 20, 2023
Showing 1-12 of 29

Last Updated: 09/26/2026